Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer Ruchika Sharma26 Sept 2025 12:00 PM ISTIndianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant,...
Dr Reddy's Labs appoints Gayatri Prabhu as Head Digital Marketing (Emerging Markets) Ruchika Sharma26 Sept 2025 11:00 AM ISTHyderabad: Dr Reddy's Labs has appointed Gayatri Prabhu as Head Digital Marketing (Emerging Markets).Gayatri is a result-driven Digital...
Alkem Labs Senior Management Personnel Amit Ghare steps down Ruchika Sharma26 Sept 2025 10:00 AM ISTMumbai: Alkem Labs has announced that Amit Ghare, a Senior Management Personnel, has tendered his resignation from the services of the...
CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses Susmita Roy25 Sept 2025 10:34 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a fresh circular outlining internal timelines and procedures for...
Tata 1mg in Advanced Talks to Raise USD 200 Million, Valuation Standoff Emerges Parthika Patel25 Sept 2025 10:30 PM ISTNew Delhi: Digital health platform Tata 1mg is in advanced talks to raise around USD 200 million, with leading global investors including Novo...
Alembic Pharma Gets USFDA Nod for Generic Paxil CR Tablets Farhat Nasim25 Sept 2025 4:06 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) for...
Game-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year Farhat Nasim25 Sept 2025 3:51 PM ISTBengaluru: Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly...
Sanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups Farhat Nasim25 Sept 2025 3:45 PM ISTNew Delhi: Sanofi Ventures has announced a new USD 625 million multiyear capital commitment from Sanofi, increasing its total assets under management...
Syneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel Susmita Roy25 Sept 2025 3:35 PM ISTNew Delhi: Following a thorough review of the Phase II clinical study protocol for Tacrolimus (T1695), the Subject Expert Committee (SEC) functioning...
Pharmacy Student from Bihar Goes Missing in Lucknow's Banthra, Search Underway Parthika Patel25 Sept 2025 3:30 PM ISTLucknow: A cloud of mystery surrounds the Banthra area after a 20-year-old pharmacy student from Bihar suddenly went missing, triggering panic among...
Zydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489 Parthika Patel25 Sept 2025 3:24 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Investigational New Drugs under the Central Drugs Standard Control Organisation (CDSCO) has...
Serum Institute, Vidal Health Partner for Digital Cashless HPV Vaccination Programme Parthika Patel25 Sept 2025 3:18 PM ISTNew Delhi: HPV vaccination in India is set for a major digital transformation as Vidal Health, a subsidiary of Bajaj Finserv Health, has partnered...
